BRIEF-Nurix Therapeutics Receives U.S. FDA Fast Track Designation For Nx-5948

Reuters12-19 21:00

BRIEF-<a href="https://laohu8.com/S/NRIX">Nurix Therapeutics</a> Receives U.S. FDA Fast Track Designation For Nx-5948

Dec 19 (Reuters) - Nurix Therapeutics Inc NRIX.O:

NURIX THERAPEUTICS RECEIVES U.S. FDA FAST TRACK DESIGNATION FOR NX-5948 FOR THE TREATMENT OF RELAPSED OR REFRACTORY WALDENSTROM’S MACROGLOBULINEMIA
NURIX THERAPEUTICS : ANTICIPATE SHARING ADDITIONAL CLINICAL DATA ABOUT ONGOING PHASE 1B EXPANSION COHORT IN 2025

Source text: ID:nGNX2tWLsG

Further company coverage: NRIX.O

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2492601127?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-19 21:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2492601127","market":"us","top_or_hot":-1,"title":"BRIEF-Nurix Therapeutics Receives U.S. FDA Fast Track Designation For Nx-5948","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/NRIX\">Nurix Therapeutics</a> Receives U.S. FDA Fast Track Designation For Nx-5948 </title></head><body><p><span>Dec 19 (Reuters)</span><span> - </span>Nurix <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc <span>NRIX.O</span>:</p><ul><li><p>NURIX THERAPEUTICS RECEIVES U.S. FDA FAST TRACK DESIGNATION FOR NX-5948 FOR THE TREATMENT OF RELAPSED OR REFRACTORY WALDENSTROM’S MACROGLOBULINEMIA</p></li><li><p>NURIX THERAPEUTICS : ANTICIPATE SHARING ADDITIONAL CLINICAL DATA ABOUT ONGOING PHASE 1B EXPANSION <a href=\"https://laohu8.com/S/CHRT.UK\">COHORT</a> IN 2025</p></li></ul><p>Source text: <span>ID:nGNX2tWLsG</span></p><p>Further company coverage: <span>NRIX.O</span></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Nurix Therapeutics Receives U.S. FDA Fast Track Designation For Nx-5948</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Nurix Therapeutics Receives U.S. FDA Fast Track Designation For Nx-5948\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-19 21:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nTUA2GNB1P:1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BRIEF-Nurix Therapeutics Receives U.S. FDA Fast Track Designation For Nx-5948 Dec 19 (Reuters) - Nurix Therapeutics Inc NRIX.O:NURIX THERAPEUTICS RECEIVES U.S. FDA FAST TRACK DESIGNATION FOR NX-5948 ...</p>\n\n<a href=\"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nTUA2GNB1P:1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nTUA2GNB1P:1","article_id":"2492601127","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2492601127","pubTimestamp":1734613211,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Nurix Therapeutics Receives U.S. FDA Fast Track Designation For Nx-5948 Dec 19 (Reuters) - Nurix Therapeutics Inc NRIX.O:NURIX THERAPEUTICS RECEIVES U.S. FDA FAST TRACK DESIGNATION FOR NX-5948 F","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","NRIX":"Nurix Therapeutics"},"translate_title":"简介-Nurix Therapeutics获得美国FDA NX-5948快速通道指定","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NRIX":0.9},"content_text":"BRIEF-Nurix Therapeutics Receives U.S. FDA Fast Track Designation For Nx-5948 Dec 19 (Reuters) - Nurix Therapeutics Inc NRIX.O:NURIX THERAPEUTICS RECEIVES U.S. FDA FAST TRACK DESIGNATION FOR NX-5948 FOR THE TREATMENT OF RELAPSED OR REFRACTORY WALDENSTROM’S MACROGLOBULINEMIANURIX THERAPEUTICS : ANTICIPATE SHARING ADDITIONAL CLINICAL DATA ABOUT ONGOING PHASE 1B EXPANSION COHORT IN 2025Source text: ID:nGNX2tWLsGFurther company coverage: NRIX.O","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2492601127"}